Skip to Content for 2006 Annual Report Menu for 2006 Annual Report About Us Menu Research Menu Development Menu Medicines Menu Investors Menu Media Menu Careers Menu
Banner Image

2006 Annual Report

Editorial Financials

Directors, Officers and Distinguished Contributors

Board of Directors

Arthur D. Levinson, Ph.D.
Chairman and Chief Executive
Officer, Genentech

Herbert W. Boyer, Ph.D.
Co-founder of Genentech
and Professor Emeritus of
Biochemistry and Biophysics
University of California, San Francisco

William M. Burns
Chief Executive Officer of the
Pharmaceuticals Division and
Member of the Corporate
Executive Committee,
The Roche Group

 

Erich Hunziker, Ph.D.
Chief Financial Officer
and Member of the Corporate
Executive Committee
The Roche Group

Jonathan K. C. Knowles, Ph.D.
Head of Global Research
and Member of the Corporate
Executive Committee
The Roche Group

Debra L. Reed
President and Chief Operating Officer,
San Diego Gas & Electric and Southern
California Gas Company

 

Officers

Arthur D. Levinson, Ph.D.*
Chairman and Chief Executive Officer

Susan D. Desmond-Hellmann, M.D., M.P.H.*
President, Product Development

Ian T. Clark*
Executive Vice President, Commercial

David A. Ebersman*
Executive Vice President and Chief Financial Officer

Stephen G. Juelsgaard, D.V.M., J.D.*
Executive Vice President, Secretary and Chief Compliance Officer

Richard H. Scheller, Ph.D.*
Executive Vice President, Research

Patrick Y. Yang, Ph.D.*
Executive Vice President, Product Operations

Hal Barron, M.D.
Senior Vice President, Development, and Chief Medical Officer

Robert L. Garnick, Ph.D.
Senior Vice President, Regulatory, Quality and Compliance

Markus Gemuend
Senior Vice President, Biochemical Manufacturing

Sean A. Johnston, J.D., Ph.D.
Senior Vice President and General Counsel

Timothy L. Moore
Senior Vice President, Global Supply Chain

John Orwin
Senior Vice President, Sales and Marketing, BioOncology

Marc Tessier-Lavigne, Ph.D.
Senior Vice President, Research Drug Discovery

William N. Anderson
Vice President, Sales and Marketing, Immunology

Robert Andreatta
Controller

Vince Anicetti
Vice President, Commercial Quality

J. Joseph Barta
Vice President, Regulatory Affairs, Technical Operations

Ronald C. Branning
Vice President, Quality Operations

David F. Broad, Ph.D.
Vice President and General Manager, Oceanside Product Operations

Charles Calderaro III
Vice President, Corporate Engineering

Peter A. Carberry, M.D.
Vice President, Clinical Operations

Scott P. Carmer
Vice President, Sales and Marketing, Rituxan Immunology

Andrew C. Chan, M.D., Ph.D.
Vice President, Immunology and Antibody Engineering

Jennifer E. Cook
Vice President, Product Portfolio Management

Vishva Dixit, M.D.
Vice President, Early Discovery Research

Gwendolyn Fyfe, M.D.
Vice President, Clinical Oncology, Avastin

Odette Go
Treasurer

Ashraf Hanna, M.D., Ph.D.
Vice President, Alliance Management and Pipeline Planning Support

Gary Harbour, Ph.D.
Vice President, Quality Assurance, South San Francisco

Roy C. Hardiman, J.D.
Vice President, Corporate Law, and Assistant Secretary

 

Kenneth J. Hillan, M.B., Ch.B.
Vice President, Development Sciences

Christopher Horan
Vice President, Planning, Distribution and Logistics

Anthony P. Hurley
Vice President, Fill/Finish Operations

Francis A. Jackson
Vice President and General Manager, Vacaville Product Operations

Charles A. Johnson, M.B., Ch.B.
Vice President, Clinical Immunology, Tissue Growth and Repair

Leonard Kanavy
Vice President, Commercial Operations

Pamela M. Klein, M.D.
Vice President, Clinical Oncology, Hematology and HER Family1

Ann L. Lee, Ph.D.
Vice President, Process Development

Kent E. Lieginger, Pharm.D.
Vice President, Managed Care and Customer Operations

Karen N. McCormick
Vice President, Sales and Marketing, Lucentis

Joseph S. McCracken, D.V.M.
Vice President, Business Development

Kevin McRaith
Vice President, Sales and Marketing, Hematology

James P. Miller
Vice President, South San Francisco
Biochemical Manufacturing

Michael P. Miller
Vice President, Sales and Marketing, HER Family1

Walter K. Moore
Vice President, Government Affairs

Genesio Murano, Ph.D.
Vice President, Regulatory, Quality and Compliance Policy and Management Operations

Varun Nanda, Ph.D.
Vice President, Sales and Marketing, Avastin

Philippa Norman
Vice President, Manufacturing Collaborations

Quinton C. Oswald
Vice President, Sales and Marketing, Tissue Growth and Repair

Todd Pierce
Vice President, Corporate Information Technology

John R. Pinion II
Vice President, Quality

Robert S. Quinn
Vice President, CIT Business and Science Applications

Todd W. Rich, M.D.
Vice President, Regulatory Affairs, Clinical and Commercial

Corsee D. Sanders, Ph.D.
Vice President, Design, Analysis, Technology and Administration (DATA) for Development Organization

David Schenkein, M.D.
Vice President, Clinical Hematology/Oncology

Mary B. Sliwkowski, Ph.D.
Vice President, Compliance and Regulatory Chemistry Manufacturing and Controls

Denise Smith-Hams
Vice President, Human Resources

Michael D. Varney, Ph.D.
Vice President, Small Molecule Drug Discovery

John M. Whiting
Vice President, Finance, and Chief Accounting Officer


* Member of Executive Committee

 

Genentech Fellow

Napoleone Ferrara, M.D.
Research

 
 

 

Senior Staff Scientist

Avi J. Ashkenazi, Ph.D.
Research

 
 

 

Staff Scientists

Thomas A. Bewley, Ph.D.
Process Development

Stuart Bunting, Ph.D.
Research

Frederic de Sauvage, Ph.D.
Research

Vishva Dixit, M.D.
Research

Paul Godowski, Ph.D.
Research

 

Peter Jackson, Ph.D.
Research

Paul Polakis, Ph.D.
Research

Steve Shire, Ph.D.
Process Development

Mark Sliwkowski, Ph.D.
Research

Richard Vandlen, Ph.D.
Research

 

Distinguished Engineers

Chung Hsu, Ph.D., P.E.
Process Development

Brad Snedecor, Ph.D.
Process Development

 

Robert van Reis
Process Development

Bradley Wolk
Process Development

 

Distinguished Programmer Analyst

Colin Watanabe
Corporate Information Technology

 
 

(1) The HER Family includes the marketed oncology products Herceptin and Tarceva.